Stem cells injected into heart arteries may help repair damage after a heart attack
Disease control
Terminated
This early-phase trial tests whether a single dose of donor stem cells (OmniMSC-AMI) given directly into the heart arteries is safe for people who have just had a major heart attack. The study enrolls adults aged 20–80 with a specific type of heart attack (anterior STEMI) who are…
Phase: PHASE1 • Sponsor: Taiwan Bio Therapeutics Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC